Matthijs J van Haren

10PUBLICATIONS
58CO-AUTHORS
Molecular targetsBiomolecular modelling and designMolecular medicineNanomaterialsNanoelectromechanical systems
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 29, 2023
MYC is a clinically significant driver of mTOR inhibitor resistance in breast cancer.

Jinhyuk Bhin, Julia Yemelyanenko, Xue Chao

|Oct 26, 2022
Synthetic Studies with Bacitracin A and Preparation of Analogues Containing Alternative Zinc Binding Groups.

Ned Buijs, Halana C Vlaming, Matthijs J van Haren

|May 17, 2022
A Direct Assay for Measuring the Activity and Inhibition of Coactivator-Associated Arginine Methyltransferase 1.

Yurui Zhang, Matthijs J van Haren, Nils Marechal

|Oct 27, 2021
Macrocyclic peptides as allosteric inhibitors of nicotinamide N-methyltransferase (NNMT).

Matthijs J van Haren, Yurui Zhang, Vito Thijssen

Pageof 2